Mice with PTEN deletion or mutation are highly susceptible to tumor development [25], and PTEN downregulation is observed in ovarian, uterine, breast, prostate, and cervical cancers [23, 24, 26]. This evidence concerns the gene PTEN and cervical carcinoma.